Home › NDC Lookup › RxCUI directory › RxCUI 204509

Polymyxin B 250000 UNT/ML Injectable Solution — RxCUI 204509

RxNorm drug concept · Semantic clinical drug
RxCUI 204509 Semantic clinical drug · SCD ● Current RxNorm concept 10 FDA products 12 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI204509
Official namePolymyxin B 250000 UNT/ML Injectable Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspolymyxin B Variable Concentration Multi-Use Injectable Solution
FDA products mapped10
Package NDCs mapped12
Reported Medicaid activity (SDUD)109 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Polymyxin B 250000 UNT/ML Injectable Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Polymyxin B 250000 UNT/ML Injectable Solution RxCUI 204509

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Polymyxin B 8536
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Polymyxin B Injectable Solution 373511
    • Polymyxin B Injectable Product 1159902
    • Injectable Solution 316949
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Polymyxin B 250000 UNT/ML 358345

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Polymyxin B 250000 UNT/ML SCDC · 358345
  • Polymyxin B Injectable Solution SCDF · 373511
  • Polymyxin B Injectable Product SCDG · 1159902

📦 FDA Products & Package NDCs

10 products · 12 package NDCs
12 package NDCs map to RxCUI 204509 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00143-9461-01 1 VIAL, GLASS in 1 CARTON (0143-9461-01) / 1 INJECTION, POW... Polymyxin B Hikma Pharmaceuticals USA Inc. 2025-09-30
00143-9461-10 10 VIAL, GLASS in 1 CARTON (0143-9461-10) / 1 INJECTION, PO... Polymyxin B Hikma Pharmaceuticals USA Inc. 2025-09-30
00143-9941-10 10 VIAL in 1 CARTON (0143-9941-10) / 1 INJECTION, POWDER, F... Polymyxin B Hikma Pharmaceuticals USA Inc. 1998-06-01
25021-0196-10 10 VIAL in 1 CARTON (25021-196-10) / 1 INJECTION, POWDER, L... Polymyxin B Sagent Pharmaceuticals 2025-10-01
55150-0234-10 10 VIAL in 1 CARTON (55150-234-10) / 1 INJECTION, POWDER, L... Polymyxin B Eugia US LLC 2016-04-04
63323-0321-10 10 VIAL in 1 TRAY (63323-321-10) / 1 INJECTION, POWDER, LYO... POLYMYXIN B Fresenius Kabi USA, LLC 2009-11-17
63323-0321-12 10 VIAL in 1 TRAY (63323-321-12) / 1 INJECTION, POWDER, LYO... POLYMYXIN B Fresenius Kabi USA, LLC 2009-11-17
63323-0367-44 10 VIAL, GLASS in 1 CARTON (63323-367-44) / 1 INJECTION, PO... Polymyxin B Fresenius Kabi USA, LLC 2015-09-09
68083-0174-10 10 VIAL in 1 CARTON (68083-174-10) / 1 INJECTION, POWDER, L... POLYMYXIN B Gland Pharma Limited 2016-06-01
70594-0049-01 1 VIAL, GLASS in 1 CARTON (70594-049-01) / 1 INJECTION, POW... Polymyxin B Xellia Pharmaceuticals USA LLC 2018-10-01
70594-0049-02 10 VIAL, GLASS in 1 CARTON (70594-049-02) / 1 INJECTION, PO... Polymyxin B Xellia Pharmaceuticals USA LLC 2018-10-01
72266-0249-10 10 VIAL in 1 CARTON (72266-249-10) / 1 INJECTION, POWDER, L... POLYMYXIN B FOSUN PHARMA USA INC 2023-08-31
Observed labelers: Fresenius Kabi USA, LLC (3) · Hikma Pharmaceuticals USA Inc. (3) · Xellia Pharmaceuticals USA LLC (2) · Eugia US LLC (1) · FOSUN PHARMA USA INC (1) · Gland Pharma Limited (1) · +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.